GoFast™: Accelerating the Future of CAR-T Cell Therapy

Enrich, harvest, and accelerate CAR-T development with a GMP-ready GoFast™ workflow – powered by the MARS® Bar platform to deliver CAR-T cells in under 48 hours.

Our mission is to enable scalable cell therapy manufacturing — with a vision to help reduce manufacturing COGS below $7,000 with GoFast^TM workflow.

Traditional CAR-T manufacturing takes 2–3 weeks, often delaying treatment for critically ill patients. GoFast™ reduces this timeline to under 72 hours, enabling faster delivery of life-saving therapy when every moment counts. Its streamlined, GMP-ready workflow also supports point-of-care manufacturing, paving the way for decentralized, more accessible treatment solutions.

WHY GoFast™ ?

A 3-Step GoFast™ CAR-T Manufacturing

1. T Cell Isolation

90% purity, >70% T cell recovery
Column-free, sterile closed system

2. Activation and Transduction

High expression in <24 hours
No extra buffer exchange needed
Direct from media to transduction

3. CAR-T Harvest

High yield, high viability
<1% viral residue, <0.2% B cell contamination
Formulation-ready or cryopreservation-compatible

AUTOMATION MEETS INNOVATION

MARS® Bar – one platform for both T cell enrichment and CAR-T cell harvest

Column-free, closed, sterile fluidics system
ISO 13485:2016 certified and GMP-ready
Compatible with fresh or frozen leukopak
Solution optimized for Applied Cells’ Ingenuity^TM reagents

GoFast™ Results

<72-hour workflow
>90% purity and >70% T cell recovery
Low viral / B cell residue
Lower cost of goods
High naïve stemness phenotype
Scalable for point-of-care manufacturing

Ready to GoFast™?

Discover All Our Products

Contact us

Applied Cells, Inc., was founded to create revolutionary solutions to complete the workflow of cell separation and enrichment.

ISO 13485:2016

Products

Technology

Applications

Customer space

Company